Literature DB >> 23484601

Nature's bounty - drug discovery from the sea.

John J Bowling1, Anna J Kochanowska, Noer Kasanah, Mark T Hamann.   

Abstract

With ∼ 40 years of research completed after the development of self-contained underwater breathing apparatus, drug discovery opportunities in the sea are still too numerous to count. Since the FDA approval of the direct-from-the-sea calcium channel blocker ziconotide, marine natural products have been validated as a source for new medicines. However, the demand for natural products is extremely high due to the development of high-throughput assays and this bottleneck has created the need for an intense focus on increasing the rate of isolating and elucidating the structures of new bioactive secondary metabolites. In addition to highlighting the drug discovery potential of the marine environment, this review discusses several of the pressing needs to increase the rate of drug discovery in marine natural products, and describes some of the work and new technologies that are contributing in this regard.

Year:  2007        PMID: 23484601      PMCID: PMC4928193          DOI: 10.1517/17460441.2.11.1505

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  68 in total

Review 1.  Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysis.

Authors:  Mark T Hamann
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

Review 2.  Drugs from the sea: conotoxins as drug leads for neuropathic pain and other neurological conditions.

Authors:  D Alonso; Z Khalil; N Satkunanthan; B G Livett
Journal:  Mini Rev Med Chem       Date:  2003-11       Impact factor: 3.862

3.  Molecular evidence for a uniform microbial community in sponges from different oceans.

Authors:  Ute Hentschel; Jörn Hopke; Matthias Horn; Anja B Friedrich; Michael Wagner; Jörg Hacker; Bradley S Moore
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

Review 4.  Chemical diversity of bioactive marine natural products: an illustrative case study.

Authors:  Valeria Costantino; Ernesto Fattorusso; Marialuisa Menna; Orazio Taglialatela-Scafati
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

Review 5.  Technology evaluation: Kahalalide F, PharmaMar.

Authors:  Mark T Hamann
Journal:  Curr Opin Mol Ther       Date:  2004-12

Review 6.  On the remarkable antitumor properties of fludelone: how we got there.

Authors:  Alexey Rivkin; Ting-Chao Chou; Samuel J Danishefsky
Journal:  Angew Chem Int Ed Engl       Date:  2005-05-06       Impact factor: 15.336

7.  Identification of the putative bryostatin polyketide synthase gene cluster from "Candidatus Endobugula sertula", the uncultivated microbial symbiont of the marine bryozoan Bugula neritina.

Authors:  Sebastian Sudek; Nicole B Lopanik; Laura E Waggoner; Mark Hildebrand; Christine Anderson; Haibin Liu; Amrish Patel; David H Sherman; Margo G Haygood
Journal:  J Nat Prod       Date:  2007-01       Impact factor: 4.050

8.  Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Authors:  H Luesch; R E Moore; V J Paul; S L Mooberry; T H Corbett
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

9.  A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.

Authors:  Aki Ishikawa; Shinichiro Motohashi; Eiichi Ishikawa; Hiroki Fuchida; Kazuko Higashino; Mizuto Otsuji; Toshihiko Iizasa; Toshinori Nakayama; Masaru Taniguchi; Takehiko Fujisawa
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

10.  Small-subunit rRNA genes and in situ hybridization with oligonucleotides specific for the bacterial symbionts in the larvae of the bryozoan Bugula neritina and proposal of "Candidatus endobugula sertula".

Authors:  M G Haygood; S K Davidson
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

View more
  1 in total

1.  Cancer Cell Inhibiting Sea Cucumber (Holothuria leucospilota) Protein as a Novel Anti-Cancer Drug.

Authors:  Ruizhen Ru; Yanzheng Guo; Juanxuan Mao; Zonghe Yu; Wen Huang; Xudong Cao; Huijian Hu; Minjie Meng; Lihong Yuan
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.